EYPT
Eyepoint Pharmaceuticals Inc
3.60$
-0.8%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +0.0% | -258.5% | – | – | – | – | – | – | – | -6,832.1% | – | |
| – | +2.9% | -10.2% | +0.0% | +40.9% | +126.8% | +1.7% | +4.6% | -11.7% | -81.0% | +231.9% | +49.9% | |
| – | +10.3% | +13.5% | +0.0% | +61.5% | +15.1% | +21.4% | +34.3% | +90.4% | -15.0% | +204.7% | -24.1% | |
| – | +10.3% | +13.5% | +1,080.0% | +69.5% | -80.8% | -21.2% | -10.4% | +476.3% | – | – | – | |
| – | +105.5% | -84.7% | -22.0% | -479.0% | – | – | -108.6% | – | – | -147.2% | – | |
| – | -35.1% | -29.8% | +30.1% | -26.5% | +97.2% | +70.0% | -56.9% | +1,278.2% | +62.0% | +16.3% | -19.1% | |
| – | -6,860.6% | – | -224.4% | +0.0% | -98.7% | +70.0% | +9,049.4% | -47.9% | -80.8% | +6,517.0% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +7,129.8% | -50.0% | +394.2% | -100.5% | -32.8% | -31.3% | +66.7% | +96.7% | -42.7% | – | – | |
| – | +0.0% | +0.0% | -6.7% | +7.2% | +29.7% | -156.4% | -99.0% | +347.3% | +6,103.8% | -99.7% | +0.0% | |
| – | -10.8% | -50.0% | +0.0% | +243.5% | +16.0% | +10.7% | +478.5% | -100.3% | – | -12.3% | +5.9% | |
| – | -55.1% | -200.6% | – | +1,280.3% | -205.3% | – | +489.0% | -162.1% | – | -197.8% | – | |
| – | – | -262.1% | – | – | – | – | – | – | – | – | – |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.